Development of a Nomogram for Predicting the Efficacy of Preoperative Chemotherapy in Osteosarcoma

References

• National Comprehensive Cancer Network [homepage on the Internet]. NCCN guidelines for patients: bone cancer; 2021. Available from: https://www.nccn.org/. Accessed August 16, 2021.
   Google Scholar
• Chou AJ, Geller DS, Gorlick R. Therapy for osteosarcoma: where do we go from here? Paediatr Drugs. 2008;10(5):315–327. doi:10.2165/00148581-200810050-00005
   PubMedGoogle Scholar
• Yu X, Yustein JT, Xu J. Research models and mesenchymal/epithelial plasticity of osteosarcoma. Cell Biosci. 2021;11(1):94. doi:10.1186/s13578-021-00600-w
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network [homepage on the Internet]. NCCN clinical practice guidelines in oncology: bone cancer; 2021. Available from: https://www.nccn.org/. Accessed August 16, 2021.
   Google Scholar
• Huang Q, Liang X, Ren T, et al. The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications. Cell Oncol. 2021;44(3):525–539. doi:10.1007/s13402-021-00598-w
   PubMed Web of Science ®Google Scholar
• Sugiu K, Tazawa H, Hasei J, et al. Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression. Cancer Chemother Pharmacol. 2021;88(3):513–524. doi:10.1007/s00280-021-04310-5
   PubMed Web of Science ®Google Scholar
• Hattinger CM, Fanelli M, Tavanti E, et al. Advances in emerging drugs for osteosarcoma. Expert Opin Emerg Drugs. 2015;20(3):495–514. doi:10.1517/14728214.2015.1051965
   PubMed Web of Science ®Google Scholar
• Hattinger CM, Fanelli M, Tavanti E, et al. Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight? Future Oncol. 2017;13(8):673–677. doi:10.2217/fon-2016-0519
   PubMed Web of Science ®Google Scholar
• Lin Z, Xie X, Lu S, Liu T. Noncoding RNAs in osteosarcoma: implications for drug resistance. Cancer Lett. 2021;504:91–103. doi:10.1016/j.canlet.2021.02.007
   PubMed Web of Science ®Google Scholar
• Schiavone K, Garnier D, Heymann MF, Heymann D. The heterogeneity of osteosarcoma: the role played by cancer stem cells. Adv Exp Med Biol. 2019;1139:187–200.
   PubMed Web of Science ®Google Scholar
• Hanafy E, Al Jabri A, Gadelkarim G, Dasaq A, Nazim F, Al Pakrah M. Tumor histopathological response to neoadjuvant chemotherapy in childhood solid malignancies: is it still impressive? J Investig Med. 2018;66(2):289–297. doi:10.1136/jim-2017-000531
   PubMed Web of Science ®Google Scholar
• Prudowsky ZD, Yustein JT. Recent insights into therapy resistance in osteosarcoma. Cancers. 2020;13(1):83. doi:10.3390/cancers13010083
   PubMed Web of Science ®Google Scholar
• Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer. 1976;37(1):1–11. doi:10.1002/1097-0142(197601)37:1<1::AID-CNCR2820370102>3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986;314(25):1600–1606. doi:10.1056/NEJM198606193142502
   PubMed Web of Science ®Google Scholar
• Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49(6):1221–1230. doi:10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Thiel DD, Jorns J, Lohse CM, Cheville JC, Thompson RH, Parker AS. Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume. Scand J Urol. 2013;47(6):472–475. doi:10.3109/21681805.2013.814071
   PubMed Web of Science ®Google Scholar
• MacMahon PJ, Kennedy AM, Murphy DT, Maher M, McNicholas MM. Modified prostate volume algorithm improves transrectal US volume estimation in men presenting for prostate brachytherapy. Radiology. 2009;250(1):273–280. doi:10.1148/radiol.2501080290
   PubMed Web of Science ®Google Scholar
• Cander S, Oz Gul O, Eylemer E, et al. Comparison of the effects of medical and surgical treatments in giant prolactinoma: a single-center experience. Hormones. 2021;20(3):491–498. doi:10.1007/s42000-021-00307-0
   PubMedGoogle Scholar
• Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188–1195. doi:10.1200/JCO.2012.41.5984
   PubMed Web of Science ®Google Scholar
• Huang YQ, Liang CH, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–2164. doi:10.1200/JCO.2015.65.9128
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180. doi:10.1016/S1470-2045(14)71116-7
   PubMed Web of Science ®Google Scholar
• Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol. 2015;33(27):3029–3035. doi:10.1200/JCO.2014.59.4895
   PubMed Web of Science ®Google Scholar
• Takahashi N, Nobusue H, Shimizu T, et al. ROCK inhibition induces terminal adipocyte differentiation and suppresses tumorigenesis in chemoresistant osteosarcoma cells. Cancer Res. 2019;79(12):3088–3099. doi:10.1158/0008-5472.CAN-18-2693
   PubMed Web of Science ®Google Scholar
• Xia WK, Liu ZL, Shen D, Lin QF, Su J, Mao WD. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma. World J Surg Oncol. 2016;14:127. doi:10.1186/s12957-016-0889-2
   PubMed Web of Science ®Google Scholar
• Chen H, Liu J, Cheng Z, et al. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: a retrospective multicenter study. Eur J Radiol. 2020;129:109066. doi:10.1016/j.ejrad.2020.109066
   PubMed Web of Science ®Google Scholar
• Jettoo P, Tan G, Gerrand CH, Rankin KS. Role of routine blood tests for predicting clinical outcomes in osteosarcoma patients. J Orthop Surg. 2019;27(2):2309499019838293. doi:10.1177/2309499019838293
   Web of Science ®Google Scholar
• Keller S, Inai R, Sato S, et al. Thallium-201 uptake of giant cell tumor: one step toward the differential diagnosis to atypically presenting osteosarcoma. AJR Am J Roentgenol. 2017;208(1):171–179. doi:10.2214/AJR.16.16359
   PubMed Web of Science ®Google Scholar
• Kerr KF, Brown MD, Zhu K, Janes H. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol. 2016;34(21):2534–2540. doi:10.1200/JCO.2015.65.5654
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574. doi:10.1177/0272989X06295361
   PubMed Web of Science ®Google Scholar
• Misaghi A, Goldin A, Awad M, Kulidjian AA. Osteosarcoma: a comprehensive review. SICOT J. 2018;4:12. doi:10.1051/sicotj/2017028
   PubMed Web of Science ®Google Scholar